Your browser doesn't support javascript.
loading
Mindfulness-based cognitive therapy vs. a health enhancement program for the treatment of late-life depression: Study protocol for a multi-site randomized controlled trial.
Bein, Magnus; Lesage, Myriam; Dikaios, Elena; Chakravarty, Mallar; Segal, Zindel; Royal, Isabelle; Speechley, Mark; Schiavetto, Alessandra; Blumberger, Daniel; Sacchet, Matthew D; Therriault, Joseph; Gruber, Johanna; Tourjman, Valerie; Richard-Devantoy, Stephane; Nair, Vasavan; Bruneau, Marie-Andrée; Rej, Soham; Lifshitz, Michael; Sekhon, Harmehr.
Afiliação
  • Bein M; Department of Psychiatry, GeriPARTy Research Group, Jewish General Hospital, Montréal, QC, Canada.
  • Lesage M; Department of Psychiatry, GeriPARTy Research Group, Jewish General Hospital, Montréal, QC, Canada.
  • Dikaios E; Department of Psychiatry, GeriPARTy Research Group, Jewish General Hospital, Montréal, QC, Canada.
  • Chakravarty M; Departments of Biological and Biomedical Engineering and Psychiatry, Centre d'imagerie cérébrale, Douglas Mental Health Institute, Verdun, QC, Canada.
  • Segal Z; University of Toronto-Scarborough, Toronto, ON, Canada.
  • Royal I; Neuropsychology Service, Department of Psychiatry, Jewish General Hospital, Montréal, QC, Canada.
  • Speechley M; Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada.
  • Schiavetto A; Department of Psychiatry, Jewish General Hospital, McGill University, Montréal, QC, Canada.
  • Blumberger D; Department of Psychiatry, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada.
  • Sacchet MD; Meditation Research Program, Department of Psychiatry, Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States.
  • Therriault J; Department of Neurology and Neurosurgery, Translational Neuroimaging Laboratory, McGill Research Centre for Studies in Aging, Douglas Mental Health Institute, Le Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l'Ouest de l'Île de Montréal, Montréal, QC, Canada.
  • Gruber J; Department of Psychiatry, GeriPARTy Research Group, Jewish General Hospital, Montréal, QC, Canada.
  • Tourjman V; Department of Psychiatry, Institut Universitaire en Santé Mentale de Montréal, Montréal, QC, Canada.
  • Richard-Devantoy S; Department of Psychiatry, Douglas Mental Health Institute, Verdun, QC, Canada.
  • Nair V; Department of Psychiatry, Douglas Mental Health Institute, Verdun, QC, Canada.
  • Bruneau MA; Département de psychiatrie et d'addictologie, Research Centre, Institut Universitaire de Gériatrie de Montréal, Montréal, QC, Canada.
  • Rej S; Department of Psychiatry, GeriPARTy Research Group, Jewish General Hospital, Montréal, QC, Canada.
  • Lifshitz M; Department of Psychiatry, Jewish General Hospital, McGill University, Montréal, QC, Canada.
  • Sekhon H; Department of Psychiatry, Jewish General Hospital, McGill University, Montréal, QC, Canada.
Front Aging Neurosci ; 14: 976636, 2022.
Article em En | MEDLINE | ID: mdl-36118690

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Idioma: En Revista: Front Aging Neurosci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Idioma: En Revista: Front Aging Neurosci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá País de publicação: Suíça